Shionogi & Co., Ltd. (SGIOY) Financials

SGIOY Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 16.2 billion 5.4 billion
March 31, 2026 16.2 billion 5.6 billion
Dec. 31, 2025 11.0 billion 1.4 billion
Sept. 30, 2025 10.9 billion 1.2 billion

SGIOY Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 239.9 million ?
March 31, 2026 540.3 million ?
Dec. 31, 2025 194.3 million ?
Sept. 30, 2025 322.1 million ?

SGIOY Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 608.6 million
March 31, 2026 299.2 million
Dec. 31, 2025 476.7 million
Sept. 30, 2025 298.6 million

SGIOY Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.8 billion - 111.7 million
March 31, 2026 4.5 billion - 118.8 million
Dec. 31, 2025 1.4 billion 114.2 million 114.2 million
Sept. 30, 2025 1.6 billion 122.7 million 122.7 million

SGIOY Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 10.5 million
March 31, 2026 10.7 million
Dec. 31, 2025 10.9 million
Sept. 30, 2025 11.5 million

SGIOY Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 28.7 million 198.0 million 281.3 million -
March 31, 2026 35.6 million 258.5 million 242.5 million -
Dec. 31, 2025 10.1 million 190.6 million 226.5 million -
Sept. 30, 2025 18.8 million 186.1 million 186.2 million -

SGIOY Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.0 billion 290.4 million
March 31, 2026 886.2 million 208.3 million
Dec. 31, 2025 942.9 million 163.7 million
Sept. 30, 2025 764.8 million 117.7 million

SGIOY

Price: $9.10

52 week price:
7.65
12.00

Dividend Yield: 2.51%

Payout Ratio Range:
0.02%
71.44%

Earnings Per Share: 0.76 USD

P/E Ratio: 11.71

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 15.2 billion

Links: